Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Champions Oncology, Inc. is a technology-driven oncology research company specializing in drug discovery and development. It operates a proprietary bank of approximately 1,500 Patient Derived Xenograft (PDX) tumor models used in advanced in vivo and ex vivo pharmacology platforms. Serving pharmaceutical and biotechnology companies globally, Champions offers research services, data licensing, and bioinformatics SaaS tools to accelerate cancer drug development through integrated computational and experimental platforms.
This description was generated via AI from an annual report. Updated about 1 year ago.